All Type of News
Drug makers in dilemma to cope with soaring raw material prices in July
Pharmaceutical business sources say that domestic pharmaceutical firms will be in woes to deal with ever-increasing demand of price increase from foreign pharmaceutical bulk manufacturers in China.
“We are quite at...
Government to earmark 658.3 billion won for health promotion fund
The government plans to spend 658.3 billion won to promote a total of 126 health-related projects this year, according to the Ministry of Health, Welfare and Family Affairs.
The plan was approved during the ministr...
Kwangdong faces damage suit
Mypharm said on May 21 it would seek 10.0 billion won in compensation from Kwangdong Pharm for sales losses caused by the Kwangdong’s illegal use of a trademark “Humassen” owned by Mypharm.
Humassen is a human pla...
Choi named Novartis Inc’s medical scientific expertNovartis Korea says its clinical chief Choi Eun-jung has started her new career in Switzerland based Novartis headquarters for one year from May 1.
Choi will responsible for ...
|
Schnell Pharm targets W20 bill. sales
Boosted by its active merger with Genexel-Sein and intensive Research and development strategy, Schnell Pharm has set an ambitious goal of 20 billion won in sales next year.
“We will inject money and energy to deve...
Three drug makers to be contested in domestic hepatitis B market
Domestic hepatitis B market will emerge as an arena of tripartite competition - GlaxoSmithKline's Zeffix (lamivudine) and Hepsera (adefovir), Bukwang Pharm's Levovir (clevudine) and BMS Korea's Baraclude (entecavir).
...
Ilaprozole goes on sale in China
Ilyang Pharm says Ilaprazole has been marketed in China since May 16. Ilaprazole 5 mg per tablet is valued at 2,100 won.
Ilyang may get about 18 billion won of annual royalty based on 10% of the net sales until 20...
Hanmi's Pidogle to benefit from health insurance
The Health Insurance Review Agency's committee said on May 21 that Hanmi Pharm's Pidogle (clopidogrel bisulfate) will be eligible for health insurance following the company's request for a government price evaluation....
Boryung Pharm Vice Chairman Kim biggest shareholder
Kim Eun-sun, the first daughter of Boryung Group's chairman Kim Seung-ho, is the second largest shareholder in Boryung Pharm, following the recent shareholding transfer, according to the company's spokesperson.
Cha...
Prices of two triptan drugs to be reduced
The Health Insurance Review Agency decided to lower health insurance prices of AstraZeneca's Zomig tablet (zolmitriptan) and GlaxoSmithKline's Naramig tablet (naratriptan) by 10.3 percent and 3.8 percent, respectively...
